[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334652-105":59,"doc-detail-334652-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","immunoradiation-therapy-for-end-stage-undifferentiated-cervical-cancer-that-restored-sensitivity-to-chemotherapy-and-resulted-in-the-disappearance-of-the-cancer","Immunoradiation Therapy for End-Stage Undifferentiated Cervical Cancer That Restored Sensitivity to Chemotherapy and Resulted in the Disappearance of the Cancer","","Among cervical cancers, small cell undifferentiated carcinoma is rare and rapidly progressive, leading to an extremely poor prognosis. During stage IV cisplatin-based chemotherapy, the patient developed drug resistance and standard therapy became infeasible. Immunoradiotherapy was administered to activate anticancer immunity, restoring cancer drug sensitivity and allowing cisplatin to succeed again. The cancer disappeared, and sustained cancer-specific immune activation helped maintain that disappearance, suggesting immunoradiotherapy may both enhance immunity and help overcome chemotherapy drug resistance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/immunoradiation-therapy-for-end-stage-undifferentiated-cervical-cancer-that-restored-sensitivity-to-chemotherapy-and-resulted-in-the-disappearance-of-the-cancer/334652/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/immunoradiation-therapy-for-end-stage-undifferentiated-cervical-cancer-that-restored-sensitivity-to-chemotherapy-and-resulted-in-the-disappearance-of-the-cancer/334652.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why was immunoradiotherapy considered in this case?","Question",{"text":112,"@type":113},"The patient developed drug resistance during cisplatin-based chemotherapy, making standard treatment no longer feasible. Immunoradiotherapy was used to activate anticancer immunity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What changes were observed after immunoradiotherapy?",{"text":117,"@type":113},"Cancer drug sensitivity to cisplatin was restored, cisplatin became effective again, and the cancer disappeared. Increased cancer-specific immunity helped maintain the disappearance.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune-related effects occurred during WT1-DC treatment?",{"text":121,"@type":113},"After WT1-DC administration, the patient developed fever, with higher fevers after later doses. The fever normalized within three days without medication.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334652,1790182422,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Open Access Case  \nReport DOI: 10.7759/cureus.57144  \nReview began 03/10/2024  \nReview ended 03/23/2024  \nPublished 03/28/2024  \n© Copyright 2024  \nNagai. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0. , which permits unrestricted use , distribution , and reproduction in any medium , provided the original author and source are credited.  \nImmunoradiation Therapy for End-Stage Undifferentiated Cervical Cancer That Restored Sensitivity to Chemotherapy and Resulted in the Disappearance of the Cancer  \nHisashi Nagai 1, 2  \n1. Human and Environmental Studies, Tokai University, Kanagawa, JPN 2. Oncology, Ginza Phoenix Clinic, Tokyo, JPN Corresponding author: Hisashi Nagai, [nagai@ginzaphoenix.jp](nagai@ginzaphoenix.jp)  \nAbstract  \nAmong cervical cancers, small cell undifferentiated carcinoma is rare. Because of its rapid progression, the prognosis is extremely poor. During the course of cisplatin-based chemotherapy for stage Ⅳ small cell undifferentiated carcinoma of the cervix, the patient developed drug resistance, and standard treatment was no longer feasible. Therefore, immunoradiotherapy was administered to activate anticancer immunity. Surprisingly, the cancer drug sensitivity was restored, and cisplatin was again successful, and the cancer disappeared. In addition, the activation of cancer-specific immunity maintained the disappearance of the cancer. It should be noted that immunoradiotherapy not only increases anti-cancer immunity but may also contribute to overcoming cancer drug resistance.  \nCategories: Obstetrics/Gynecology, Allergy/Immunology, Oncology  \nKeywords: liver metastatis, gyanecologic oncology, regenerative therapy, oncoimmunology, cancer immunotherapy  \nIntroduction  \nAmong cervical cancers, small cell undifferentiated carcinoma is rare. Because of its extremely rapid progression, median survival is estimated to be less than one year [1,2] . Undifferentiated cancers are prone to acquire drug resistance to chemotherapy. Overcoming drug resistance is a very important issue in cancer treatment because the inability to administer chemotherapy means the end of standard treatment. In this regard, radiotherapy has been shown to have the potential to restore the sensitivity of cancer to drugs, which is a promising approach for a different purpose than the elimination of cancer. However, there have been few clinical reports [3,4] .  \nRecently, immunoradiation therapy, which combines radiation therapy and immunotherapy, has attracted much attention. In immunoradiation therapy, irradiation increases the immunogenicity of cancer and enhances the anticancer immune response, thereby increasing the clinical efficacy of immunotherapy [5] .  \nIn the case of this paper, immunoradiotherapy was administered to a patient with end-stage undifferentiated cervical cancer. As a result, the drug sensitivity was restored, and the ineffective anticancer drug became effective again. The cancer disappeared. The patient was able to continue the disappearance of cancer due to the increase in anti-cancer immunity.  \nCase Presentation  \nA woman in her 50s underwent a wide hysterectomy, bilateral adnexectomy, and pelvic lymph node dissection after discovering cervical cancer two years earlier. Pathological examination revealed small cell undifferentiated carcinoma.  \nTumor markers such as SCC, CEA, and CA125 were all negative. This patient 's cervical cancer was of a nature not accompanied by elevated tumor markers. Cisplatin (63 mg, 1w x 4 times) was administered as postoperative chemotherapy and 50Gy/25f as postoperative radiation therapy. Three weeks after completion of treatment, right supraclavicular fossa lymph node metastasis, paratracheal lymph node metastasis, and liver metastasis were detected by CT. Therefore, paclitaxel 280 mg/w and cisplatin 94 mg/w were started, and radiotherapy was simultaneously added at 50Gy/25fto the right supraclavicular fossa and paratrachea","cbCaikVc5mjaTUVQ","https://ap.wps.com/l/cbCaikVc5mjaTUVQ","pdf",535415,"English","# Introduction\n# Case Presentation\n## Treatment timeline and progression\n## Immunoradiotherapy and outcomes\n## Immune response observations\n# How to Cite","[{\"question\":\"Why was immunoradiotherapy considered in this case?\",\"answer\":\"The patient developed drug resistance during cisplatin-based chemotherapy, making standard treatment no longer feasible. Immunoradiotherapy was used to activate anticancer immunity.\"},{\"question\":\"What changes were observed after immunoradiotherapy?\",\"answer\":\"Cancer drug sensitivity to cisplatin was restored, cisplatin became effective again, and the cancer disappeared. Increased cancer-specific immunity helped maintain the disappearance.\"},{\"question\":\"What immune-related effects occurred during WT1-DC treatment?\",\"answer\":\"After WT1-DC administration, the patient developed fever, with higher fevers after later doses. The fever normalized within three days without medication.\"}]","Immunoradiation Therapy for End-Stage Undifferentiated Cervical Cancer That Restored Sensitivity to Chemotherapy and Resulted in the Disappearance of the Cancer | PDF",1790007652,15]